Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of KRP-N118 for nocturia due to nocturnal polyuria
jRCT2080224041Phase 2Completed
- Sponsor
- Kyorin Pharmaceutical
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in nocturia and nocturnal polyuria (NP) comparing KRP-N118 with Placebo (2 arms). Started Sep 2018; status: completed.
02
Drugs
lazuvapagon
03
Conditions
nocturianocturnal polyuria (NP)
Beyond the preview
Go deeper on jRCT2080224041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224041.